hydrazine has been researched along with Lymphoma, Large-Cell, Anaplastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrogio, C; Bombelli, S; Casati, C; Ceccon, M; Chiarle, R; Compagno, M; Di Giacomo, F; Gambacorti-Passerini, C; Giudici, G; Manazza, AD; Mastini, C; Menotti, M; Merlo, MEB; Mologni, L; Poggio, T; Rigolio, R; Turner, SD; Varesio, LM; Voena, C | 1 |
1 other study(ies) available for hydrazine and Lymphoma, Large-Cell, Anaplastic
| Article | Year |
|---|---|
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency.
Topics: Animals; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Cells, Cultured; Crizotinib; Dose-Response Relationship, Drug; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Histones; Humans; Hydrazines; Lymphoma, Large-Cell, Anaplastic; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Microscopy, Confocal; Nucleophosmin; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles; Pyridines; RNA Interference; Signal Transduction; Transplantation, Heterologous; Triazoles | 2016 |